Skip to main content
. Author manuscript; available in PMC: 2011 Oct 13.
Published in final edited form as: N Engl J Med. 2010 Sep 2;363(10):954–963. doi: 10.1056/NEJMcp1001011

Table 4.

TREATMENT RECOMMENDATIONS FOR PREVENTION OF IDIOPATHIC CALCIUM STONES IN ADULTS

Treatment Mechanism of action Doses Selection criteria Potential complications
Fluids Lowers supersturation by dilution of solutes Adequate to maintain urine volume > 2 liters daily. Useful for all SF. May be used as sole treatment for patients with a single stone episode. Avoid fluids containing excess salt or carbohydrates
Diet Lowers supersaturation by decreasing calcium and oxalate excretion Na < 100 mmol/day Protein < 0.8–1 gm animal protein/kg BW Especially useful for hypercalciuric or hyperuricosuric SF. May be hard to maintain
Oxalate < 100 mg/day Hyperoxaluric SF May be hard to maintain
Maintains bone mineral, prevents hyperoxaluria Calcium 800–1000 mg/day All calcium SF Should obtain from dietary sources, avoid supplements
Thiazide-type diuretics Lowers supersaturation by decreasing calcium excretion Chlorthalidone 12.5–50 mg daily Indapamide 1.25–2.5 daily Hydrochlorothiazide 12.5–25 mg twice daily Hypercalciuric SF, may be useful for some normocalciuric SF Hypokalemia, lowers blood pressure (may be desirable), allergy and sun sensitivity
Potassium alkali Lowers supersaturation by chelating calcium Inhibits calcium crystal growth Potassium citrate 10–20 meq bid-tid Hypocitraturic SF Monitor urine pH and CaP SS, avoid SS > 1
Allopurinol Lowers urine uric acid concentration, which may improve solubility of calcium salts 100–300 mg/day (may be taken once daily) Hyperuricosuric calcium SF Allergy, may be severe.